Weekly news updates are currently posted on the Internet site and sent out via e-blast to provide up-to-date information on what has been covered in the news regarding hepatitis C in the previous week. Topics include all stories related to hepatitis C as well as personal stories and events.
Week Ending 07/27/2014
“Hepatitis is one of the top four communicable diseases in the world, with someone contracting the potentially fatal liver condition every 10 seconds. Advocates are using World Hepatitis Day, Monday July 28, to draw attention to the disorder. They are optimistic that drugs – which can cure the viral disease – will become available to those who need them the most.”
“Sovaldi, a drug to cure Hepatitis C, made headlines when it was approved in December as a breakthrough in treatment for this chronic and potentially fatal liver disease.”
Phase 2 COSMOS Study Results Published in The Lancet Demonstrate Efficacy and Safety of Janssen’s Once-Daily Simeprevir in All Oral 12-Week Combination with Sofosbuvir for Genotype 1 Chronic Hepatitis C
“Study evaluated interferon-free combination in treatment-naïve and prior null-responder patients with all stages of liver fibrosis, including cirrhosis.”
CINCINNATI—“Treatment of HIV patients co-infected with the hepatitis C virus (HCV) with an anti-retroviral drug therapy not only tackles HIV, but also reduces HCV replication, according to a new study led by a University of Cincinnati researcher.”
“People who inject drugs and are enrolled in a drug treatment program are open to receiving education and treatment for hepatitis C, according to new research by investigators at several institutions, including Weill Cornell Medical College.”